| Keywords: |
adult; child; review; salvage therapy; antineoplastic agents; antineoplastic agent; neoplasm; neoplasms; metabolism; neoplasm proteins; drug effect; drug resistance; drug screening; drug resistance, neoplasm; enzyme inhibitor; arsenic trioxide; arsenicals; leukemia, promyelocytic, acute; oxides; drug antagonism; protein processing; protein processing, post-translational; enzyme inhibitors; chromatin; chemically induced disorder; tumor protein; promyelocytic leukemia; neurologic disease; gastrointestinal disease; leukocytosis; histone deacetylases; retinoic acid; histone deacetylase; arylbutyric acid derivative; acetylation; china; gastrointestinal diseases; nervous system diseases; 4 phenylbutyric acid; drug evaluation; tretinoin; organoarsenic derivative; oxide; phenylbutyrates; humans; human; melarsoprol; 4-phenylbutyric acid
|
